The Centers for Medicare and Medicaid Services approved in January a narrow coverage for FDG-PET imaging of cervical cancer. Medicare will reimburse for the initial staging of cervical cancer in a patient with a negative CT or MRI for extrapelvic metastatic disease.
The Centers for Medicare and Medicaid Services approved in January a narrow coverage for FDG-PET imaging of cervical cancer. Medicare will reimburse for the initial staging of cervical cancer in a patient with a negative CT or MRI for extrapelvic metastatic disease.
"We're disappointed the coverage didn't include restaging," said Dr. R. Ed Coleman, president of the Academy of Molecular Imaging. "Referring physicians, however, can send restaging cases to the new national PET data registry, which should be available in the spring."
The American College of Radiology Imaging Network, in conjunction with the AMI, will manage the national registry. The government will monitor the data and make coverage decisions based on the effectiveness of PET in currently uncovered indications.
"If we didn't have the registry, the restrictive cervical cancer approval would be a concern," Coleman said.
Although cervical cancer affects mostly younger women, Medicare approval will make the test more palatable for referring physicians, said Ronald Lissak, owner of Integral PET Associates in New York City.
The industry does a poor job of educating referring physicians, Lissak said. Any legitimacy conferred by the government can help persuade physicians that PET is a valuable test.
Beyond the government's imprimatur, referring physicians need to see more peer-reviewed articles and case studies, and PET imaging needs to be included in more research protocols, he said.
For more information from the Diagnostic Imaging archives:
PET reimbursement depends on clinical trials and data registry
CMS will cover PET in Alzheimer's disease
PET/CT profitability hinges on building the market
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.